Bimekizumab Latest Price Guide for 2026
Bimekizumab is an innovative biologic indicated for the treatment of moderate to severe plaque psoriasis, particularly in patients who have failed other conventional treatments. Its mechanism of action reduces inflammatory reactions, effectively reduces skin damage, and restores patients' skin health through dual targeting of IL-17A and IL-17F. The advantage of bichizumab lies in its high efficacy and potential for long-term disease control, especially in the treatment of psoriasis, which outperforms traditional single-targeted drugs.
Regarding the market price of bicizumab, although the drug has been launched in China, it has not yet been included in medical insurance, so the price is relatively high. According to current market information, the retail price of 160 mg/1 vial of bicizumab is approximately RMB 3 to 4,000 per box. However, this price may fluctuate depending on region, sales channel and market supply and demand.

Overseas, it is more expensive than chiclizumab.The original drug, 160 mg/2 vials, sells for approximately RMB 40,000 to RMB 50,000 per box. Due to the high production and R&D costs of bicizumab, coupled with import costs and market pricing strategies, the price in overseas markets is significantly higher than domestic prices. This may cause some patients to face a greater financial burden, especially if they are not covered by medical insurance.
It is worth noting that there are currently no generic drugs of bicizumab on the market, so patients can only choose the original drug. As market demand grows and more research data accumulates, generic drugs may appear in the future. By then, drug prices are expected to be further reduced and patients' treatment burden will be reduced accordingly.
Overall, although the therapeutic efficacy of bicizumab is advantageous in the treatment of psoriasis, its higher price is still a challenge faced by many patients. With the gradual improvement of medical insurance policies and the emergence of generic drugs, it is expected that the use of this drug will gradually become more popular and economical.
Keyword tags: Bimekizumab, Bimekizumab, psoriasis, biological agents, drug prices, medical insurance, original drugs, generic drugs, immunotherapy, drug applications
Reference materials:https://www.medicines.org.uk/emc/product/12833/smpc
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)